Literature DB >> 16986135

Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele.

Thomas M Kessler1, Jakob Lackner, Gustav Kiss, Peter Rehder, Helmut Madersbacher.   

Abstract

AIMS: To investigate whether upper urinary tract function and the need for surgery in patients with myelomeningocele depends on the timing of initiating neurourological management. PATIENTS AND METHODS: One hundred thirty-three patients with myelomeningocele were included in our retrospective study. The patients were divided based on age at the initial evaluation into three categories: from day of birth to age 2 (group 1, n = 67), from age 3 to age 10 (group 2, n = 44), and after age 10 (group 3, n = 22). Upper urinary tract function and the need for surgery with the intention to preserve or normalize the upper urinary tract function were compared between the three groups.
RESULTS: Mean follow-up was 11, 10, and 9 years in group 1, 2, and 3, respectively. The upper urinary tract function was normal in 91%, 80%, and 82% at the initial evaluation (P = 0.194) and in 99%, 86%, and 86% at the last follow-up (P = 0.012) in group 1, 2, and 3, respectively. Following failure of conservative therapy only, the proportions of patients undergoing surgical interventions with the intention to preserve or normalize the upper urinary tract function was significantly (P = 0.0002) different among the three groups: 15%, 34%, and 59%, respectively.
CONCLUSIONS: Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele in the long-term. Therefore, initiation of proactive neurourological management as early as possible, ideally from the day of birth, is strongly recommended. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16986135     DOI: 10.1002/nau.20304

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

Review 1.  Management of Neurogenic Bladder.

Authors:  Venkataramani Sripathi; Aparajita Mitra
Journal:  Indian J Pediatr       Date:  2017-05-29       Impact factor: 1.967

Review 2.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

Review 3.  Pharmacotherapy for Pediatric Neurogenic Bladder.

Authors:  Paweł Kroll
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

Review 4.  Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review.

Authors:  Paul W Veenboer; J L H Ruud Bosch; Floris W A van Asbeck; Laetitia M O de Kort
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 5.  The neurogenic bladder: medical treatment.

Authors:  Carla Verpoorten; Gunnar M Buyse
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

Review 6.  Preventing kidney injury in children with neurogenic bladder dysfunction.

Authors:  Faezeh Javadi Larijani; Mastaneh Moghtaderi; Nilofar Hajizadeh; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.